Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, ...
A curated review of what has happened in endometrial cancer research in 2024, including expert commentary, FDA approvals, healthcare disparities, AI, immunotherapies, and more.
MI Cancer Seek has received approval from the FDA as a companion diagnostic test to identify those who may benefit from ...
The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback